<!doctype html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7" lang=""> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8" lang=""> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9" lang=""> <![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js" lang="en">
<!--<![endif]-->

<!--Designerd by: http://bootstrapthemes.co-->

<head>
	<meta charset="utf-8">
	<title>MüschenLab</title>
	<meta name="description" content="">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<link rel="icon" type="image/png" href="assets/images/favicon.png">

	<!--Google Font link-->
	<link href="https://fonts.googleapis.com/css?family=Montserrat:400,700" rel="stylesheet">
	<link href="https://fonts.googleapis.com/css?family=Raleway:400,600,700" rel="stylesheet">
	<link href="https://fonts.googleapis.com/css?family=Open+Sans:300,400,600,700" rel="stylesheet">


	<link rel="stylesheet" href="assets/css/slick.css">
	<link rel="stylesheet" href="assets/css/slick-theme.css">
	<link rel="stylesheet" href="assets/css/animate.css">
	<link rel="stylesheet" href="assets/css/fonticons.css">
	<link rel="stylesheet" href="assets/css/font-awesome.min.css">
	<link rel="stylesheet" href="assets/css/bootstrap.css">
	<link rel="stylesheet" href="assets/css/magnific-popup.css">
	<link rel="stylesheet" href="assets/css/bootsnav.css">


	<!--For Plugins external css-->
	<!--<link rel="stylesheet" href="assets/css/plugins.css" />-->

	<!--Theme custom css -->
	<link rel="stylesheet" href="assets/css/style.css">
	<!--<link rel="stylesheet" href="assets/css/colors/maron.css">-->

	<!--Theme Responsive css-->
	<link rel="stylesheet" href="assets/css/responsive.css" />

	<script src="assets/js/vendor/modernizr-2.8.3-respond-1.4.2.min.js"></script>
</head>

<body data-spy="scroll" data-target=".navbar-collapse">

	<!-- Preloader -->
	<div id="loading">
		<div id="loading-center">
			<div id="loading-center-absolute">
				<div class="object" id="object_one"></div>
				<div class="object" id="object_two"></div>
				<div class="object" id="object_three"></div>
				<div class="object" id="object_four"></div>
			</div>
		</div>
	</div>
	<!--End off Preloader -->

	<div class="culmn">
		<!--Home page style-->

		<nav class="navbar navbar-light navbar-expand-lg  navbar-fixed white no-background bootsnav">
			<!-- Start Top Search -->
			<div class="top-search">
				<div class="container">
					<div class="input-group">
						<span class="input-group-addon"><i class="fa fa-search"></i></span>
						<input type="text" class="form-control" placeholder="Search">
						<span class="input-group-addon close-search"><i class="fa fa-times"></i></span>
					</div>
				</div>
			</div>
			<!-- End Top Search -->

			<div class="container">

				<!-- Start Header Navigation -->
				<div class="navbar-header">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#navbar-menu">
            <span></span>
            <span></span>
            <span></span>
          </button>
					<a class="navbar-brand" href="#brand">
          	<img src="assets/images/logo.png" class="logo logo-display m-top-10" alt="">
            <img src="assets/images/logo.jpg" class="logo logo-scrolled m-top-10" alt="">
          </a>
				</div>
				<!-- End Header Navigation -->

				<!-- Collect the nav links, forms, and other content for toggling -->
				<div class="collapse navbar-collapse" id="navbar-menu">
					<ul class="nav navbar-nav navbar-right" data-in="fadeInDown" data-out="fadeOutUp">
						<li><a href="#hello">Home</a></li>
						<li><a href="#research">Research</a></li>
						<li><a href="#apps">Apps</a></li>
						<li><a href="#papers">Papers</a></li>
						<li><a href="#members">Lab members</a></li>
						<li><a href="#contact">Contact</a></li>
					</ul>
				</div>
				<!-- /.navbar-collapse -->
			</div>

		</nav>

		<!--Home Sections-->

		<section id="hello" class="home bg-mega">
			<div class="overlay"></div>
			<div class="container">
				<div class="row">
					<div class="main_home">
						<div class="home_text">
							<h1 class="text-white">Mechanisms of B-cell dynamics & Oncogenic signaling</h1>
						</div>

						<div class="home_btns m-top-40">
							<a href="#papers" target="_blank" class="btn-primary m-top-20">READ OUR PAPERS</a>
							<a href="#apps" target="_blank" class="btn-default m-top-20">EXPLORE OUR DATA</a>
						</div>

					</div>
				</div>
				<!--End off row-->
			</div>
			<!--End off container -->
		</section>
		<!--End off Home Sections-->


		<!--About Sections-->
		<section id="research" class="about roomy-100">
			<div class="container">
				<div class="row">
					<div class="main_about">
						<div class="col-md-6">
							<div class="about_content">
								<h2>OUR RESEARCH</h2>
								<div class="separator_left"></div>

								<p>Less than 1 in 2,000 cells in the human body are B-cells.
									Once activated, B-cells divide at a faster rate than any other cell type and produce antibodies to neutralize foreign pathogens.
									Unlike other cell types, B-cells undergo multiple rounds of somatic gene recombination and hypermutation of immunoglobulin genes to evolve antibodies that bind to antigen with high affinity.
									Hence, adaptive immune protection by B-cells comes with an approximately 300-fold increased risk of malignant transformation compared to other cell types.
									B-cell leukemia/lymphoma represent the most frequent type of cancer in children (31%) and account for 10% of all cancers in adults.</p>


								<p>To prevent the production of harmful autoantibodies and autoimmune disease, autoreactive B-cells and pre-malignant clones are eliminated by a process termed negative selection.
									Despite strict and rigorous negative selection, B-cells frequently give rise to autoimmune diseases and B-cell malignancies such as leukemia and lymphoma.
									Since humans can live without B-cells for extended periods of time, the Müschen laboratory systematically investigated lineage-specific vulnerabilities that are common in B-cell leukemia/lymphoma but not any other cell type.
									Contrary to established dogma, these mechanisms are not only active in preventing autoimmune disease but also represent a novel class of therapeutic oncogenic targets in malignant B-cell tumors.
									Over the past five years, the Müschen Laboratory established innovative conceptual frameworks for the understanding of B-cell signaling mechanisms and negative selection, some of which are summarized to the right: </p>

								<div class="about_btns m-top-40">
									<a href="" class="btn btn-primary">READ OUR PAPERS NOW</a>
								</div>
							</div>
						</div>
						<div class="col-md-6">
							<div class="about_accordion wow fadeIn">
								<div id="faq_main_content" class="faq_main_content">
									<h6><i class="fa fa-angle-right"></i> METABOLIC GATEKEEPERS </h6>
									<div>
										<div class="content">
											<p>B-cells not only have the smallest cytoplasmic volume but also fewer mitochondria than any other cell type.
												The new paradigm on ‘metabolic gatekeeper functions’ is based on B-lymphoid transcription factors repressing or limiting glucose-uptake and energy-supply to set
												low thresholds for negative selection of autoreactive and premalignant B-cells
												(Chan et al., 2017; Pan et al., 2021). </p>

										</div>
									</div>
									<!-- End off accordion item-1 -->

									<h6 class="open"><i class="fa fa-angle-right"></i> GOLDILOCKS PRINCIPLE </h6>
									<div class="open">
										<div class="content">
											<p>Thresholds of B-cell selection are based on signaling strength of the B-cell receptor (BCR).
												While B-cells with a non-functional BCR lack critical BCR-signals for survival, autoreactive B-cells elicit overwhelming strong BCR-signals.
												According to a Goldilocks principle of B-cell selection, only clones with intermediate BCR-signaling strength (“just right”) are positively selected to survive and proliferate.
												Targeted hyperactivation of BCR-downstream kinases mimics excessive signaling strength from autoreactive BCRs, thus triggering negative selection.
												Traditional cancer therapy is focused on kinase inhibitors to suppress oncogenic signaling so kinase hyperactivation is a novel approach for targeted therapy in B-cell malignancies
												(Müschen 2018; Müschen 2019). </p>
										</div>
									</div>
									<!-- End off accordion item-2 -->

									<h6> <i class="fa fa-angle-right"></i> PI3K FEEDBACK LOOP</h6>
									<div>
										<div class="content">
											<p>The endosomal protein IFITM3 was found to play a role as a central scaffold for lipid-raft assembly and surface-expression of rafts-associated receptors during B-cell activation.
												Recruitment of IFITM3 is critical for the initiation of PI3K-signaling, antibody affinity maturation and oncogenic B-cell transformation
												(Lee et al., 2020). </p>
										</div>
									</div>
									<!-- End off accordion item-3 -->

									<h6><i class="fa fa-angle-right"></i> DIVERGENT ONCOGENIC SIGNALING </h6>
									<div>
										<div class="content">
											<p>Only mutations that converge on one central pathway promote leukemia-progression.
												Genetic reactivation of divergent (suppressed) pathways engage conflicting biochemical and transcriptional programs and subvert leukemia development.
												Pharmacological pathway-reactivation to create a diverse signaling environment can be leveraged as a new therapeutic to prevent leukemia progression
												(Chan et al, 2020).</p>
										</div>
									</div>
									<!-- End off accordion item-4 -->
								</div>
							</div>
						</div>
					</div>
				</div>
				<!--End off row-->
			</div>
			<!--End off container -->
			<br />

		</section>
		<!--End off About section -->

		<!--Apps Section-->
		<section id="apps" class="portfolio lightbg">
			<div class="container">
				<div class="row">
					<div class="main_portfolio roomy-100">
						<div class="col-md-8 mr-md-auto ml-md-auto">
							<div class="head_title text-center">
								<h2>APPS</h2>
								<div class="separator_auto"></div>
								<p>As part of our commitment to open science we created a suite of simple to use apps to allow wet-lab scientists to easily explore
									and visualize data generated in our lab, as well as tools to explore public data related to B-cell malignancies. </p>
								<p>All code is openly available on our <a href="#contact">GitHub page</a></p>
								<p>Hover over the app logos below to learn more.</p>
							</div>
						</div>
						<div class="row">
							<div class="portfolio_content">
								<div class="row">


									<div class="col-md-3">
										<div class="portfolio_item">
											<img src="assets/images/hex/drug_discovery.png" alt="" />
											<div class="portfolio_hover text-center">
												<h6 class="text-uppercase text-white">Drug discovery</h6>
												<p class=" text-white">Compare protein-dependency in your cell-type of interest to other tumor-types to identify cell-type specific therapeutic targets
													                     Integrates cell-type dependency data from CRISPR, RNAi & drug screens.</p>
												<div class="portfolio_hover_icon">
													<a href="drug_discovery"><i class="fa fa-expand"></i></a>
												</div>
											</div>
										</div>
									</div>

									<div class="col-md-3">
										<div class="portfolio_item">
											<img src="assets/images/hex/functional_studies.png" alt="" />
											<div class="portfolio_hover text-center">
												<h6 class="text-uppercase text-white">Functional studies</h6>
												<p class=" text-white">Vizualize & explore functional studies from our lab</p>
                        <a href=""></a>
												<div class="portfolio_hover_icon">
													<a href="functional_studies"><i class="fa fa-expand"></i></a>
												</div>
											</div>
										</div>
									</div>

									<div class="col-md-3">
										<div class="portfolio_item">
											<img src="assets/images/hex/clinical_outcomes.png" alt="" />
											<div class="portfolio_hover text-center">
												<h6 class="text-uppercase text-white">Clinical outcomes</h6>
												<p class=" text-white">Database of clinical micro-array based studies for exploring the prognostic effects of gene expression</p>
												<div class="portfolio_hover_icon">
													<a href="clinical_outcomes"><i class="fa fa-expand"></i></a>
												</div>
											</div>
										</div>
									</div>

									<div class="col-md-3">
										<div class="portfolio_item">
											<img src="assets/images/hex/cl_phenotypes.png" alt="" />
											<div class="portfolio_hover text-center">
												<h6 class="text-uppercase text-white">Cell line phenotypes</h6>
												<p class=" text-white">Molecular phenotype data (RNAseq, proteomics, metabolomics) on cancer cell lines</p>
												<div class="portfolio_hover_icon">
													<a href="cl_phenotypes"><i class="fa fa-expand"></i></a>
												</div>
											</div>
										</div>
									</div>

								</div>
							</div>
						</div>
					</div>
				</div>
				<!--End off row -->
			</div>
			<!--End off container -->
		</section>
		<!-- End off Portfolio section-->

		<!--Blog Section-->
		<section id="blog" class="blog">
			<div class="container">
				<div class="row">
					<div class="main_blog text-center roomy-100">
						<div class="col-sm-8 mr-sm-auto ml-sm-auto">
							<div class="head_title text-center">
								<h2>SELECTED PUBLICATIONS</h2>
								<div class="separator_auto"></div>
							</div>
						</div>

						<div class="row">
							<div class="col-md-4">
								<div class="blog_item m-top-20">
									<div class="blog_item_img">
										<img src="assets/images/ss/ifitm3.png" alt="IFITM3" />
									</div>
									<div class="blog_text roomy-40">
										<h5>IFITM3 functions as PIP3-scaffold to amplify PI3K signaling in B-cells</h5>
										<p><a href="https://www.nature.com/articles/s41586-020-2884-6">The endosomal protein IFITM3 was found to play a role as a central scaffold for lipid-raft assembly and surface-expression of rafts-associated receptors during B-cell activation.
											Recruitment of IFITM3 is critical for the initiation of PI3K-signaling, antibody affinity maturation and oncogenic B-cell transformation </a></p>
									</div>
								</div>
							</div>
							<div class="col-md-4">
								<div class="blog_item m-top-20">
									<div class="blog_item_img">
										<img src="assets/images/ss/staterk.png" alt="STAT_ERK" />
									</div>
									<div class="blog_text roomy-40">
										<h5>Signalling input from divergent pathways subverts malignant B-cell transformation</h5>
										<p><a href="https://www.nature.com/articles/s41586-020-2513-4">Only mutations that converge on one central pathway promote leukemia-progression.
											Genetic reactivation of divergent (suppressed) pathways engage conflicting biochemical and transcriptional programs and subvert leukemia development.
											Pharmacological pathway-reactivation to create a diverse signaling environment can be leveraged as a new therapeutic to prevent leukemia progression
											(Chan et al, 2020).</a></p>
									</div>
								</div>
							</div>
						</div>

					</div>
				</div>
				<!--End off row -->
			</div>
			<!--End off container -->
		</section>
		<!-- End off Blog section-->


		<!--Contact Us Section-->
		<section id="contact" class="contact bg-mega fix">
			<div class="container">
				<div class="row">
					<div class="main_contact roomy-100 text-white">
						<div class="col-md-4">
							<div class="rage_widget">
								<div class="widget_head">
									<h3 class="text-white">Connect with us</h3>
									<div class="separator_small"></div>
								</div>
								<p>Follow us on Twitter, LinkedIn, or GitHub, or see available positions & contact us via our Yale website </p>

								<div class="widget_socail m-top-30">
									<ul class="list-inline-item">
										<li><a href="https://twitter.com/muschenlab"><i class="fa fa-twitter"></i></a></li>
										<li><a href="https://www.linkedin.com/in/markus-m%C3%BCschen-4b316529/"><i class="fa fa-linkedin"></i></a></li>
										<li><a href="https://github.com/muschenlab"><i class="fa fa-github"></i></a></li>
										<li><a href="https://medicine.yale.edu/lab/muschen"><i class="fa fa-globe"></i></a></li>
									</ul>
								</div>
							</div>
						</div>
					</div>
				</div>
				<!--End off row -->
			</div>
			<!--End off container -->
		</section>
		<!--End off Contact Section-->

		<!-- scroll up-->
		<div class="scrollup">
			<a href="#"><i class="fa fa-chevron-up"></i></a>
		</div>
		<!-- End off scroll up -->

	</div>

	<!-- JS includes -->

	<script src="assets/js/vendor/jquery-1.11.2.min.js"></script>
	<script src="assets/js/vendor/popper.min.js"></script>
	<script src="assets/js/vendor/bootstrap.min.js"></script>
	<script src="assets/js/jquery.magnific-popup.js"></script>
	<script src="assets/js/jquery.easing.1.3.js"></script>
	<script src="assets/js/slick.min.js"></script>
	<script src="assets/js/jquery.collapse.js"></script>
	<script src="assets/js/bootsnav.js"></script>
	<script src="assets/js/plugins.js"></script>
	<script src="assets/js/main.js"></script>

</body>

</html>
